Elsevier
  Sign Up Send Feedback Tell a Friend Search Archive View Sample
 
Weekly E-Mail newsletter
For physicians in Internal Medicine, Cardiology, Geriatrics, Women's Health,
and Adolescent Medicine
News from hundreds of top industry sources
It's what clinicians need to know
It's FREE!
   
  About SmartBrief

About The American Journal of Medicine, published by Elsevier

About Elsevier

Visit other Elsevier Health Science publications

Privacy Policy
   
Send AJMPlus story to a colleague.

* Your Name
* Your E-mail
* Friend's E-mail
Separate multiple addresses with commas.
  Personal Message
* Indicates required fields
Terms and Conditions: You must submit valid e-mail addresses only. Use of e-mail addresses is subject to the terms of SmartBrief's privacy policy.
Here's the story you're sending:
Unnecessary antinuclear antibody testing
In this retrospective study, more than 90% of patients who were referred to a tertiary rheumatology clinic for a positive ANA test result had no evidence for an ANA-associated rheumatic disease. The poor predictive value of a positive ANA in this cohort was largely attributable to unnecessary testing in patients with low pretest probabilities for ANA-associated rheumatic disease.  American Journal of Medicine, The (4/2013)